JPRN-UMIN000031259尚未招募未知
Glucocorticoid-tapering aimed maintenance therapy in patients with systemic lupus erythematosus - BLISS-POST
First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan0 个研究点目标入组 100 人开始时间: 2018年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •a) Patients who contraindicated by package insert of BLM. b) Receipt of B cell depleted therapy (biologic agent) within 1 year. c) Receipt of cyclophosphamide (Endoxan) within 6 months. d) Receipt of high dose GC (prednisolone equivalent 1mg/kg) within 6 months. e) Receipt of plasma exchange within 6 months. f) Have developed clinical evidence of significant, unstable or uncontrolled, acute or chronic diseases not due to SLE (i.e., cardiovascular, pulmonary, hematologic, gastrointestinal, hepatic, renal, neurological, malignancy or infectious diseases). g) Have developed any other medical diseases (e.g., cardiopulmonary), laboratory abnormalities, or conditions (e.g., poor venous access) that in the opinion of the principal investigator, makes the subject unstable for the study.
研究者
相似试验
招募中
4 期
BLISS-POSTSystemic Lupus ErythematosusJPRN-jRCTs071190045Tanaka Yoshiya100
进行中(未招募)
不适用
ocal Glucocorticoid Injektion in the Treatment of Benign Oesophageal Strictures, a Randomized Clinical StudyPatients with benign oesophageal strictures and symptoms where dilatation of the stricture is planned.MedDRA version: 8.1Level: LLTClassification code 10030199Term: Oesophageal strictureEUCTR2006-005856-33-SEThe Department of Molecular Medicin and Surgery, P9:03, Karolinska Institutet60
进行中(未招募)
1 期
Cortisol in personalized treatment for posttraumatic stress disorder (PTSD)EUCTR2020-000712-30-NLRadboudumc190
招募中
3 期
Targeted glucocorticoid administration to improve safety learning in PTSD patients with HPA axis dysregulatioNL-OMON52772Radboud Universitair Medisch Centrum190
已完成
4 期
Drug therapy for the prevention of glucocorticoid induced osteoporosis in elderly patients: teriparatide or bisphosphonates?glucocorticoid-induced osteoporosisJPRN-UMIN000009222Department of Rheumatology & Clinical Immunology,Saitama Medical Center, Saitama Medical Universitity40
